Leslie Harrold to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Leslie Harrold has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.963
-
Litman HJ, Sheffield KM, Pugach O, Shan M, Lakin P, Cui ZL, Curtis SE, Johnston JA, Harrold LR. Applying Bias Correction Methods to Build Hybrid Controls Using Real-World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis. Pharm Stat. 2025 Jul-Aug; 24(4):e70020.
Score: 0.963